- Digitalis for treatment of heart failure in patients in sinus rhythm
- Digoxin for preventing or treating neonatal respiratory distress syndrome
- Dipyridamole for preventing stroke and other vascular events in patients with vascular disease
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement
- Disease management interventions for heart failure
- Distal aortic perfusion during thoracoabdominal aneurysm repair for prevention of paraplegia
- Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation
- Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease
- Diuretics for heart failure
- Diuretics for Ménière's disease or syndrome
- Diuretics for preventing pre‐eclampsia
- Diuretics for respiratory distress syndrome in preterm infants
- Diuretics for transient tachypnoea of the newborn
- Dopamine versus no treatment to prevent renal dysfunction in indomethacin‐treated preterm newborn infants
- Dressings and topical agents for arterial leg ulcers
- Dressings for healing venous leg ulcers
- Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes
- Drugs and pacemakers for vasovagal, carotid sinus and situational syncope
- Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)
- Drugs for preventing red blood cell dehydration in people with sickle cell disease
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.
